# Fixed-Free HTN Trial

Study · id `cardio:ct-nct03578042` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03578042](<https://clinicaltrials.gov/study/NCT03578042>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03578042

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03578042. Randomized; no masking; primary purpose treatment. Start 2017-04-01 (actual); primary completion 2019-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03578042, source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)
- Started: 2017-04-01 (actual) (ClinicalTrials.gov record NCT03578042, source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)
- Primary completion: 2019-09-30 (anticipated) (ClinicalTrials.gov record NCT03578042, source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)
- Completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT03578042, source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)
- Countries: Lebanon (ClinicalTrials.gov record NCT03578042, source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03578042-2018-07-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Fixed-Free HTN Trial
- Condition: Hypertension
- Intervention (Drug): Losartan and amlodipine and hydrochlorothiazide
- Intervention (Drug): Standard of care
- Lead sponsor: Hotel Dieu de France Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 42d6264ade303303eeab4103c4925ef0e29531bfd30d67286ccf03a0b42da2c4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
